Predictors of Discharge Diuretic Prescription Duration and Medication Adherence in Heart Failure [0.03%]
心力衰竭患者出院时利尿剂用药时间和依从性的预测因素
Aradhana Verma,Neil Kalwani,Jun Fan et al.
Aradhana Verma et al.
Daan C H Ceelen,Lukas Baumhove,Bart J van Essen et al.
Daan C H Ceelen et al.
Introduction: Acute heart failure (AHF) remains a major cause of mortality and rehospitalization, with successful decongestion being the primary therapeutic goal. Plasma interleukin-6 (IL-6) levels are elevated in AHF, as...
Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry [0.03%]
基于人工智能表型的一百万多名退伍军人的心力衰竭特征和结局：全国DCVA-HF注册项目
Sijian Zhang,Venkatesh K Raman,Yijun Shao et al.
Sijian Zhang et al.
Background: Major heart failure (HF) registries are limited by manual chart abstraction and to hospitalized patients. Using artificial intelligence (AI) approaches and electronic health record (EHR) data from the Veterans...
Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific Statement [0.03%]
射血分数轻度降低的心力衰竭：美国心力衰竭学会科学声明
Jane E Wilcox,Lars H Lund,Zachary L Cox et al.
Jane E Wilcox et al.
Heart failure (HF) has been categorized for years according to ejection fraction (EF) into patients with reduced (HFrEF) and preserved EF (HFpEF). In 2016, guidelines from the European Society of Cardiology recognized a third group, initial...
Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies [0.03%]
肥厚型心肌病合并左心室收缩功能障碍：药物、器械及高级心脏康复治疗的整合
Masih Tajdini,Kiarash Tavakoli,Sydney C Jenkin et al.
Masih Tajdini et al.
Hypertrophic cardiomyopathy with left ventricular systolic dysfunction (HCM-LVSD) is a severe manifestation of HCM defined by left ventricular ejection fraction
Robert J Mentz
Robert J Mentz
Faris Araj,Anas Jawaid,Mark H Drazner et al.
Faris Araj et al.
Performance of the HFpEF-ABA, H2FPEF, and HFA-PEFF Algorithms in HFpEF: A Participant-Level Pooled Analysis of Randomized Clinical Trials [0.03%]
HFpEF-ABA、H2FPEF和HFA-PEFF算法在HFpEF患者中的表现：随机临床试验的受试者水平汇总分析
John W Ostrominski,Fernando A Lara Lince,Brian L Claggett et al.
John W Ostrominski et al.
Background: Several scores have been introduced to improve diagnosis of heart failure (HF) with preserved ejection fraction (HFpEF), but whether these scores enhance risk stratification in established HFpEF remains uncert...
Invasive assessment of coronary microvascular dysfunction in patients with wild-type transthyretin amyloid cardiomyopathy [0.03%]
野生型甲状腺素转运蛋白淀粉样变性心肌病患者冠状动脉微血管功能障碍的侵入式评估
Daisuke Sunohara,Yasushi Ueki,Masatoshi Minamisawa et al.
Daisuke Sunohara et al.
Background: Coronary microvascular dysfunction (CMD) is frequently observed in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM). We aimed to investigate the prevalence of CMD and identify factors a...